Identification of SEC61G as a Diagnostic and Prognostic Biomarker in Oral Squamous Cell Carcinoma
Oral squamous cell carcinoma (OSCC) is a heterogeneous malignancy originating from the oral mucosal epithelium. Detecting novel biomarkers can offer crucial information on disease aggressiveness and expected clinical outcomes for individual patients. SEC61G, an aberrantly expressed gene in various c...
Main Authors: | Shi-Long Zhang, Lei Chen, Lin-Lin Bu, Zi-Li Yu, Si-Rui Ma |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/10/2718 |
Similar Items
-
Expression of SEC61G in Oral Squamous Cell Carcinoma and Its Prognostic Value
by: GAO Rui, et al.
Published: (2023-12-01) -
High SEC61A1 expression predicts poor outcome of acute myeloid leukemia
by: Ji Guo, et al.
Published: (2024-03-01) -
SEC61 translocon subunit gamma enhances low-dose cisplatin-induced cancer-stem cell properties of head and neck squamous cell carcinoma via enhancing Ca2+-mediated autophagy
by: Xiangbin Bu, et al.
Published: (2023-10-01) -
The Sec61 translocon is a therapeutic vulnerability in multiple myeloma
by: Antoine Domenger, et al.
Published: (2022-01-01) -
Sec61β facilitates the maintenance of endoplasmic reticulum homeostasis by associating microtubules
by: Yimeng Zhu, et al.
Published: (2017-11-01)